Trump's drug importation plan faces resistance in US, Canada

The Hill

1 December 2019 - President Trump’s proposal to import cheaper prescription drugs from Canada faces significant headwinds from U.S. pharmaceutical companies and the Canadian government.

Canadian officials warn their country is too small to supply their neighbors to the south with prescription drugs, an argument that American drugmakers quickly seized on after years of aggressively opposing all drug importation efforts.

But Trump — eager for a win on drug prices amid the impeachment inquiry and heading into 2020 — is showing no signs of backing off.

Read The Hill article

Michael Wonder

Posted by:

Michael Wonder